1f19bee78d84b1104.UMsR707tr-ct_4s7S7NszNjpNHgx_21fFmcP4zR7BAU.Bp9OsCyaya0blrpWONUvpIeGdygcqgITfRE-h1Y4c1U4mCWfK4_fvUWq5A
11-05 Earnings Flash (AORT) Artivion, Inc. Reports Q3 Revenue $123.8M, vs. FactSet Est of $121.0M MT
11-05 Earnings Flash (AORT) Artivion, Inc. Posts Q3 Adjusted EPS $0.08 per Share, vs. FactSet Est of $0.07 MT
11-05 Artivion, Inc., Q3 2026 Earnings Call, Nov 05, 2026
11-05 Artivion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
11-05 Artivion Reports Third Quarter 2026 Financial Results PR
11-05 Artivion, Inc. Narrows Earnings Guidance for the Full Year 2026 CI
10-28 Artivion to Participate in Upcoming Investor Conferences PR
10-22 Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results PR
10-20 Jefferies Initiates Artivion at Buy With $31 Price Target MT
09-11 Artivion Insider Sold Shares Worth $286,656, According to a Recent SEC Filing MT
08-20 Artivion Insider Sold Shares Worth $2,026,850, According to a Recent SEC Filing MT
08-07 Artivion's Q2 Adjusted Earnings Decline, Revenue Increases MT
08-06 Artivion, Inc., Q2 2026 Earnings Call, Aug 06, 2026
08-06 Earnings Flash (AORT) Artivion, Inc. Reports Q2 Revenue $125.8M, vs. FactSet Est of $120.0M MT
08-06 Earnings Flash (AORT) Artivion, Inc. Posts Q2 Adjusted EPS $0.13 per Share, vs. FactSet Est of $0.10 MT
08-06 Artivion: Q2 Earnings Snapshot AQ
08-06 Artivion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-06 Artivion Reports Second Quarter 2026 Financial Results PR
07-28 Artivion to Participate in Upcoming Investor Conferences PR
07-23 Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results PR
06-29 Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Defensive Index CI
06-29 Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Value Benchmark Index CI
06-29 Artivion's Hybrid Prosthesis Device Gets FDA Premarket Approval; Shares Up Pre-Bell MT
06-29 Artivion Receives Fda Approval for Amds Hybrid Prosthesis CI
06-29 Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Value Benchmark CI

Become a member to access more news

New member
No results match your criteria